Navigation Links
AssureRx Expands GeneSightRx® Pharmacogenetic Profile with Sixth Gene to Enhance Guidance of Psychiatric Drug Prescribing
Date:2/14/2011

CINCINNATI, Feb. 14, 2011 /PRNewswire/ -- AssureRx Health, Inc. today announced that it has expanded its laboratory-developed GeneSightRx® pharmacogenetic test with a sixth gene, CYP2C9, to further support clinicians in prescribing medications for behavioral health patients.

The addition of the CYP2C9 gene, variations of which can cause loss of function involved in the metabolism of certain psychotropic medications, provides physicians with further information on gene polymorphisms responsible for variations in the metabolism of antidepressant and antipsychotic medications. GeneSightRx will now measure and analyze fifty clinically important genetic variants of six genes that affect patients' response to medications prescribed in psychiatric medicine.

The enhanced six-gene Web-based therapeutic decision support product analyzes genetic variants which may affect a patient's ability to tolerate or respond to psychotropic medications. GeneSightRx integrates the analysis of genes and their variations to obtain an evidence-based pharmacogenetic profile. These gene variations are then analyzed against 26 FDA-approved drugs to help physicians select the appropriate psychotropic medications for each patient. In addition to the CYP2C9 gene, GeneSightRx analyzes genetic variations in the CYP2D6, CYP2C19, and CYP1A2 genes, as well as the serotonin transporter gene SLC6A4 and the serotonin 2A receptor gene 5HTR2A.  

"GeneSightRx provides objective measures to help physicians avoid prescribing drugs that may cause adverse drug reactions or poor response in certain patients. Improving drug safety is a key company objective," said James S. Burns, president & CEO of AssureRx. "Our goal is to build the leading medical informatics company providing pharmacogenetic and other treatment decision support products to help physicians individualize the t
'/>"/>

SOURCE AssureRx Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AssureRx Appoints Senior Executives in Key Roles to Drive Company Growth
2. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
3. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
4. Cellectar Expands Clinical Management Team
5. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
6. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
7. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
8. PAREXEL Expands Global Clinical Pharmacology Capabilities
9. BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
10. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
11. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2, 2015 Research and Markets ( http://www.researchandmarkets.com/research/275q7t/inhaled_drug ... Drug Delivery (London, UK - November 19-20, 2015)" ... Delivery meeting will cover industry case studies, regulatory updates, ... Co-Chairmen are Dr Steven Nichols , OINP Specialist ... Companies participating include: ...
(Date:9/2/2015)... Miss. , Sept. 2, 2015   Gulf Coast Tattoo ... removal services with the cutting-edge Astanza Duality laser in ... unwanted ink erase their tattoo regret and take back control of ... but extends its services to Biloxi ... region. "With tattoo regret being as prevalent as it ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cnq7tc/medical_device ) ... Device Studies: Clinical Evidence (London, UK - November ... This course has been designed specifically ... evidence required for medical devices and in-vitro diagnostic ... devices and the emphasis on high quality, appropriate ...
Breaking Medicine Technology:Gulf Coast Tattoo Removal Delivers Unrivaled Tattoo Removal Results To Biloxi And Gulfport With Astanza Duality 2Medical Device Studies: Clinical Evidence Course - London, UK - November 10-11, 2015 2
... , July 7 /PRNewswire-FirstCall/ ... a biopharmaceutical company focused on the development of novel ... completed the dosing of the last patient in NIL-CDNP-CT005, ... in patients with acute decompensated heart failure, or ADHF. ...
... , LOUISVILLE, Ky. , July 6 ... of Revonto™ (dantrolene sodium for injection), the first patented ...  The time to reconstitute dantrolene sodium for injection has ... the solution is clear.  Revonto™ retains the cost-savings of ...
Cached Medicine Technology:Nile Therapeutics Completes Dosing of Phase II Study 2Nile Therapeutics Completes Dosing of Phase II Study 3US WorldMeds Announces the Launch of Revonto™ (dantrolene sodium for injection) 2
(Date:9/2/2015)... ... September 02, 2015 , ... ... intermediate or final products. Automating sample handling makes density measurements more efficient and ... each step of the automated workflow and the advantages compared to manual sample ...
(Date:9/2/2015)... ... September 02, 2015 , ... A UPMC and ... earned international recognition as a premier center for treatment of and research into ... internal bleeding and stroke. , Cure HHT, previously known as The HHT ...
(Date:9/2/2015)... ... 2015 , ... Ericson is a noted speaker and educator in the field ... of Education for the Association for Clinical Documentation Improvement Specialists (ACDIS) where she developed ... She serves as a CDI subject matter expert for a variety of HCPro and ...
(Date:9/2/2015)... Chicago, IL (PRWEB) , ... September 02, 2015 ... ... (COIES) is officially announced today. The two day international investment and business conference ... House Oct 9-11, 2015 in Beijing China. The full-weekend networking conference will feature ...
(Date:9/2/2015)... ... September 02, 2015 , ... SonicSurg ... extremity surgical market, announced today that more than 600 successful patient procedures have ... hand. Plus, nearly 70 of these procedures have been on triggering thumbs. ...
Breaking Medicine News(10 mins):Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 3Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 4Health News:The 2015 China Overseas Investment and Entrepreneurship Summit (COIES) Announced 2Health News:Trigger Tome Surpasses 600 Successful Patient Procedures 2
... But they are still just as sensitive as anyone else. Ignoring ... so//. ,Members of the "stronger sex" often expect a ... Many only consult a doctor when it's too late and could ... ,German men have a life expectancy of around 76 years, compared ...
... have long known the molecular mechanisms behind most of the ... part by rhodopsin, a pigment molecule that is extremely sensitive ... signals that can be decoded by the brain into visual ... a one-degree change in temperature has remained a mystery. ...
... the annual Compendium of Health Statistics published by the Office ... by caesarian method. This is costing the NHS twice as ... in 1995, the deliveries by C section have increased to ... women from 1995 to 2006. There is an increase of ...
... at the Conference on Retroviruses and Opportunistic Infections in ... Sunday. ,Health professionals made the present scenario ... ravaging South Africa known here. ,The meeting ... to report the latest scientific news on the spread ...
... Delhi: Nearly half of India's children below the age of three ... to bed hungry every day, says new data.// ,The ... Programme (WFP) say 45.9 percent of Indian children under the age ... weight in relation to their height and age. ,"The ...
... people exposed to toxic gases from the Union Carbide plant ... Bhopal gas tragedy Sunday demanded free treatment of the children ... ,The Bhopal tragedy occurred on the night of ... iso-cyanate (MIC) spewed out of the pesticide plant, in one ...
Cached Medicine News:Health News:Men Not as Tough as They Seem 2Health News:Researchers Discover Key to Body’s Ability to Detect Subtle Temperature Change 2Health News:Researchers Discover Key to Body’s Ability to Detect Subtle Temperature Change 3Health News:XDR-TB: the Latest Global Terror 2Health News:Bhopal Gas Victims Demand Treatment of Children With Birth Defects 2
Round handle colibri tying forceps with 5 mm titanium coated platforms. Length 100 mm....
Round handle curved tying forceps with 5 mm titanium coated platforms. Length 110 mm....
Tennant curved tying forceps with extra delicate smooth jaws, 6 mm tying platform, For 9-0 to 11-0 sutures. Overall length 108 mm....
Catalano curved tying forcep has 6 mm V-grove tying platform. Overall length 100 mm....
Medicine Products: